Build status - In Progress

For persons with drug-resistant focal onset seizures, a type of Epilepsy, the study of of cvl-865 as adjunctive therapy.

For persons with drug-resistant focal onset seizures, a type of Epilepsy, the study of of cvl-865 as adjunctive therapy.
Recruiting
18 years - 99 years
All
Phase 2
120 participants needed
1 Location

Brief description of study

Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Epilepsy,focal onset seizures
  • Age: 18 years - 99 years
  • Gender: All

Male or Female, Age 18 or older focal onset seizures, a type of Epilepsy,

Updated on 04 Aug 2024. Study ID: 834546

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center